| |
| |
|
| Insider
Information: |
Musso Alan A |
| Relationship: |
CFO and Treasurer |
| City: |
Winston-Salem |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
84,347 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$31,537 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
84,347 |
|
|
| Total
Value |
$31,537 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
SVP, Fin+Admin, CFO & ... |
2014-10-17 |
57,799 |
|
0 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
CFO and Treasurer |
2018-05-25 |
26,548 |
2014-12-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2018-05-25 |
4 |
AS |
$7.97 |
$49,466 |
D/D |
(6,206) |
26,548 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2018-01-03 |
4 |
D |
$9.79 |
$6,912 |
D/D |
(706) |
32,754 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2018-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
33,460 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2017-12-11 |
4 |
AS |
$9.33 |
$159,667 |
D/D |
(17,117) |
31,585 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2017-11-27 |
4 |
S |
$9.89 |
$61,382 |
D/D |
(6,206) |
48,702 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2017-05-25 |
4 |
S |
$12.24 |
$77,254 |
D/D |
(6,311) |
54,908 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2016-11-28 |
4 |
AS |
$19.23 |
$443,160 |
D/D |
(23,027) |
60,548 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2016-11-25 |
4 |
AS |
$20.48 |
$128,480 |
D/D |
(6,273) |
83,575 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2015-11-24 |
4 |
AS |
$22.34 |
$654,459 |
D/D |
(29,300) |
88,742 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
CFO and Treasurer |
• – – |
2014-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
117,647 |
117,647 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Fin+Admin, CFO & Treas |
• – – |
2014-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
57,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2011-06-07 |
4 |
OE |
$5.10 |
$166,340 |
D/D |
30,875 |
33,674 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2011-06-07 |
4 |
S |
$21.80 |
$672,973 |
D/D |
(30,875) |
2,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-12-22 |
4 |
S |
$26.47 |
$129,200 |
D/D |
(4,881) |
2,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-12-22 |
4 |
OE |
$5.10 |
$24,893 |
D/D |
4,881 |
7,680 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-12-21 |
4 |
S |
$26.61 |
$413,386 |
D/D |
(15,535) |
2,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-12-21 |
4 |
OE |
$5.10 |
$79,229 |
D/D |
15,535 |
18,334 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-28 |
4 |
S |
$24.60 |
$36,900 |
D/D |
(1,500) |
2,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-28 |
4 |
OE |
$2.93 |
$4,395 |
D/D |
1,500 |
4,299 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-26 |
4 |
S |
$24.65 |
$49,295 |
D/D |
(2,000) |
2,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-26 |
4 |
OE |
$2.93 |
$5,860 |
D/D |
2,000 |
4,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-25 |
4 |
S |
$24.69 |
$209,892 |
D/D |
(8,500) |
2,799 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-25 |
4 |
OE |
$2.93 |
$24,905 |
D/D |
8,500 |
11,299 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-22 |
4 |
OE |
$2.93 |
$1,758 |
D/D |
600 |
3,399 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
• – – |
2010-10-22 |
4 |
S |
$24.60 |
$14,760 |
D/D |
(600) |
2,799 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
